Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Catalent Inc (CTLT)

109.38   0.12 (0.11%) 04-13 08:24
Open: 108.5 Pre. Close: 109.26
High: 109.795 Low: 107.9925
Volume: 1,014,916 Market Cap: 18,619M
Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. It has a collaboration with the Janssen Pharmaceutical Companies; Arcturus Therapeutics Holdings Inc.; and BrainStorm Cell Therapeutics Inc. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 109.922 - 110.344 110.344 - 110.767
Low: 106.867 - 107.38 107.38 - 107.893
Close: 108.556 - 109.338 109.338 - 110.121

Technical analysis

as of: 2021-04-12 4:51:38 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 130.87     One year: 152.85
Support: Support1: 104.65    Support2: 100.08
Resistance: Resistance1: 112.04    Resistance2: 130.87
Pivot: 105.88
Moving Average: MA(5): 107.85     MA(20): 105.73
MA(100): 107.46     MA(250): 91.89
MACD: MACD(12,26): -0.24     Signal(9): -1.09
Stochastic oscillator: %K(14,3): 71.93     %D(3): 63.88
RSI: RSI(14): 55.23
52-week: High: 127.68  Low: 54.21  Change(%): 93.0
Average Vol(K): 3-Month: 105688  10-Days: 76876

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CTLT has closed below upper band by 15.1%. Bollinger Bands are 33.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 12 Apr 2021
Is CTLT Stock A Buy or Sell? - Yahoo Finance

Fri, 09 Apr 2021
Catalent Inc (CTLT) gains 1.71% for April 09 - Equities.com

Thu, 08 Apr 2021
Catalent Inc (CTLT) gains 1.19% for April 08 - Equities.com

Wed, 07 Apr 2021
Catalent Inc (CTLT) falls 0.81% for April 07 - Equities.com

Wed, 07 Apr 2021
Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine - Yahoo Finance

Wed, 07 Apr 2021
Catalent Inc (CTLT) gains 1.21% for April 06 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 170
Shares Float (M) 169
% Held by Insiders 0.56
% Held by Institutions 101.73
Shares Short (K) 2,340
Shares Short P. Month (K) 2,040

Stock Financials

EPS 1.800
EPS Est This Year 1.630
EPS Est Next Year 1.820
Book Value (p.s.) 20.310
Profit Margin 9.98
Operating Margin 14.88
Return on Assets (ttm) 4.5
Return on Equity (ttm) 11.3
Qtrly Rev. Growth 26.3
Gross Profit (p.s.) 5.776
Sales Per Share 20.325
EBITDA (p.s.) 4.623
Qtrly Earnings Growth 94.30
Operating Cash Flow (M) 518
Levered Free Cash Flow (M) -256

Stock Valuations

PE Ratio 60.77
PEG Ratio
Price to Book value 5.39
Price to Sales 5.38
Price to Cash Flow 35.94

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.